Viewing StudyNCT00184080



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00184080
Status: COMPLETED
Last Update Posted: 2014-05-21
First Post: 2005-09-13

Brief Title: Elsamitrucin SPP 28090 in Patients With Relapsed or Refractory Non-Hodgkins Lymphoma
Sponsor: University of Southern California
Organization: University of Southern California

Organization Data

Organization: University of Southern California
Class: OTHER
Study ID: 13NHL-04-1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Southern California
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Luigi Lenaz
Old Organization: Spectrum Pharmaceuticals Inc

Collaborators

Name Class
Spectrum Pharmaceuticals Inc INDUSTRY